ASCENDIS PHARMA A/S - ADR (ASND)

US04351P1012 - ADR

135.9  -1.03 (-0.75%)

After market: 135.9 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
266.72M51.17M7.78M6.95M13.38M
Cost Of Goods
44.40M12.14M3.52MN/AN/A
Gross Profit
222.32M39.04M4.26MN/AN/A
Operating Expenses
670.03M600.85M456.05M337.57M240.09M
Research and Development
395.32M368.73M285.77M248.71M182.40M
Selling, General, and Administrative Expenses
258.30M215.85M155.59M72.56M45.77M
Operating Income
-447.71M-561.81M-451.79M-330.62M-226.72M
Interest Income/Expense
-18.60M-11.68M67.85M-88.55M8.47M
Other Income/Expense
0.00-4.32MN/AN/AN/A
Non Recurring Items
-7.83MN/AN/AN/AN/A
Income Before Taxes
-474.14M-577.82M-383.94M-419.17M-218.25M
Income Tax
7.30M5.38M-370.00K-220.00K-230.00K
Net Income
-481.45M-583.19M-383.58M-418.96M-218.02M
EBITDA
-428.80M-543.86M-436.39M-321.17M-220.03M
 
Per Share Data
EPS Diluted Total Ops
-8.55-10.39-6.99-8.27-4.69
Non GAAP EPS
-8.56-10.40-7.01-8.24-4.72
 
Statistics
Gross Profit Margin
83.36%76.29%54.76%N/AN/A
Profit Margin
-180.51%-1139.71%-4930.33%-6028.20%-1629.45%
Operating Profit Margin
-167.86%-1097.93%-5807.07%-4757.12%-1694.47%

All data in EUR

Charts